Jiangsu Hengrui Medicine Investor Relations Material
Latest events
H1 2025
20 Aug, 2025
Q1 2025
25 Apr, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Jiangsu Hengrui Medicine
Access all reports
Jiangsu Hengrui Medicine Co., Ltd. is a China-based pharmaceutical company engaged in the research, development, production, and distribution of innovative medicines. The company focuses on therapeutic areas such as oncology, anesthesiology, cardiology, and endocrinology. It offers a diverse portfolio of pharmaceutical products, including chemical drugs, biologics, and injectables. The company is headquartered in Lianyungang, China, and its shares are listed on the Shanghai Stock Exchange.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
600276
Country
🇨🇳 China